Structural requirements for nicotinic antagonists in the CNS.
Martin
T J
TJ
Department of Pharmacology and Toxicology, Medical College of Virginia-Virginia Commonwealth University, Richmond 23298-0613.
Suchocki
J
J
May
E L
EL
Martin
B R
BR
D000818:Animals; D001921:Brain / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D008464:Mecamylamine / Q000031:analogs & derivatives* / Q000494:pharmacology; D051379:Mice; D009043:Motor Activity / Q000187:drug effects*; D009538:Nicotine / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D009619:Nociceptors / Q000187:drug effects*; D011930:Reaction Time / Q000187:drug effects; D011978:Receptors, Nicotinic / Q000187:drug effects*; D013329:Structure-Activity Relationship
D011978:Receptors, Nicotinic; D008464:Mecamylamine; D009538:Nicotine